However, since CD4+ T cells were the predominant T cell subset that drove GVHD pathogenesis in these tested models, we interpret this to mean that the GVHD alleviation resulted from the reduced CD4+ T cell activation in allo-BMT. This evidence concerns the gene CD4 and graft versus host disease.